SI-BONE Inc. [SIBN] stock is up 0.90 while the S&P 500 has fallen -0.64% on Wednesday, 10/14/20. While at the time of this article, SIBN ATR is sitting at 1.32. This stock’s volatility for the past week remained at 7.23%, while it was 5.15% for the past 30-day period. SIBN has risen $0.21 from the previous closing price of $23.38 on volume of 0.9 million shares.
On 15, October 2020, SI-BONE Announces Pricing of Public Offering of Common Stock. According to news published on Yahoo Finance, SI-BONE, Inc. (Nasdaq: SIBN) (“SI-BONE”), a Silicon Valley-based medical device company focused on the development of implantable devices used in the surgical treatment of the sacropelvic anatomy, today announced the pricing of its underwritten public offering of 3,190,053 shares of its common stock at a price to the public of $22.00 per share. Of the shares of common stock being offered, 3,000,000 shares are being offered by SI-BONE and 190,053 shares are being offered by a selling stockholder. Gross proceeds to SI-BONE from the offering are expected to be $66.0 million, before deducting underwriting discounts and commissions and estimated offering expenses. SI-BONE will not receive any proceeds from the sale of the shares of common stock by the selling stockholder in the offering. The offering is scheduled to close on October 19, 2020, subject to the satisfaction of customary closing conditions. In addition, SI-BONE has granted the underwriters a 30-day option to purchase up to an additional 478,507 shares of common stock on the same terms and conditions.
Analyst Birdseye View:
The most recent analyst activity for SI-BONE Inc. [NASDAQ:SIBN] stock was on June 16, 2020, when it was Resumed with an Overweight rating from Cantor Fitzgerald, which also raised its 12-month price target on the stock to $25. Before that, on August 04, 2020, Needham Recapitulated a Buy rating and elevated its amount target to $24. On May 05, 2020, Needham Reiterated a Buy rating and plunged its price target on this stock from $27 to $22. On February 19, 2020, Needham Initiated a Buy rating and increased its price target to $27. On January 08, 2020, SunTrust Initiated a Buy rating and increased its price target to $27. On December 18, 2019, Cantor Fitzgerald Initiated an Overweight rating and boosted its amount on this stock to $27. On November 12, 2018, Morgan Stanley Initiated an Overweight rating and boosted its target amount on this stock to $24. On November 12, 2018, JMP Securities Initiated a Mkt outperform rating and improved its amount target to $27.
In the past 52 weeks of trading, this stock has oscillated between a low of $7.20 and a peak of $26.41. Right now, the middling Wall Street analyst 12-month amount mark is $27.00. At the most recent market close, shares of SI-BONE Inc. [NASDAQ:SIBN] were valued at $23.59. According to the average price forecast, investors can expect a potential return of 2.63%.
SI-BONE Inc. [NASDAQ:SIBN] most recently reported quarterly sales of 14.05 billion, which represented growth of -14.10%. This publicly-traded organization’s revenue is $256,874 per employee, while its income is -$146,576 per employee. This company’s Gross Margin is currently 88.40%, its Operating Margin is -61.50%, its Pretax Margin is -57.06, and its Net Margin is -57.06. Continuing to look at profitability, this corporation’s Return on Assets, Equity, Whole Principal & invested Principal is sitting at -30.06, -50.13, -28.35 and -33.83 respectively.
The Principal structure of this organization shows its whole liability to whole principal at 38.37 and the whole liability to whole assets at 33.52. It shows enduring liability to the whole principal at 34.10 and enduring liability to assets at 0.30 while looking for an extended time period.
Readers are usually of view to make a close observation to the indicators that support and make resistance before moving to any particular stock. As of now, the company’s stock is sitting at 22.75 points at 1st support level, the second support level is making up to 22.12. But as of 1st resistance point, this stock is sitting at 24.43 and at 25.47 for 2nd resistance point.
SI-BONE Inc. [SIBN] reported its earnings at -$0.44 per share in the fiscal quarter closing of 6/29/2020. The Analysts for Wall Street were expecting to report its earnings at -$0.64/share signifying the difference of 0.2 and 31.20% surprise value. Comparing the previous quarter ending of 3/30/2020, the stated earnings were -$0.47 calling estimates for -$0.38/share with the difference of -0.09 depicting the surprise of -23.70%.
Important Ratio’s To Watch
Meanwhile, turning our focus to liquidity, the Current Ratio for SI-BONE Inc. [NASDAQ:SIBN] is 13.20. Likewise, the Quick ratio is also the same, showing Cash ratio at 4.89. Now if looking for a valuation of this stock’s amount to sales ratio it’s 7.89 and it’s amount to book ratio is 8.59.
The most recent insider trade was by Pisetsky Michael A, GC & Chief Compliance Officer, and it was the sale of 3000.0 shares on Sep 18. RECUPERO ANTHONY J, the Chief Commercial Officer, completed a sale of 3000.0 shares on Sep 16. On Sep 14, FRANCIS LAURA, Chief Financial Officer, completed a sale of 2547.0 shares.